Recent Quotes
My Watchlist
Indicators
Markets
Stocks
ETFs
Tools
Markets:
Overview
News
Currencies
International
Treasuries

Articles published by Seer, Inc.

Seer to Report Third Quarter 2025 Financial Results on November 6, 2025
From Seer, Inc.
Via GlobeNewswire
Tickers SEER
Seer Highlights How Proteomics Complements Genomics to Advance Precision Medicine at American Society of Human Genetics (ASHG) 2025
From Seer, Inc.
Via GlobeNewswire
Tickers SEER
Seer Appoints Isaac Ro to its Board of Directors
From Seer, Inc.
Via GlobeNewswire
Tickers SEER WGS
Seer to Participate in the Morgan Stanley 23rd Annual Global Healthcare Conference
From Seer, Inc.
Via GlobeNewswire
Tickers SEER
Seer Reports Second Quarter 2025 Financial Results and Reiterates Full Year 2025 Outlook
From Seer, Inc.
Via GlobeNewswire
Tickers SEER
Seer to Participate in the Canaccord Genuity 45th Annual Growth Conference
From Seer, Inc.
Via GlobeNewswire
Tickers SEER
Seer to Report Second Quarter 2025 Financial Results on August 6, 2025
From Seer, Inc.
Via GlobeNewswire
Tickers SEER
Seer’s Proteograph Platform Enables Unprecedented 20,000-Sample Proteomics Study with Korea University to Develop AI-Driven Diagnostics for Cancers in Young Adults
From Seer, Inc.
Via GlobeNewswire
Tickers SEER
Seer Redefining Deep Unbiased Proteomics with Launch of New Proteograph Workflow at ASMS 2025, Enabling Previously Unattainable Scale and Efficiency
From Seer, Inc.
Via GlobeNewswire
Tickers SEER
Seer Reports First Quarter 2025 Financial Results and Reiterates Full Year 2025 Outlook
From Seer, Inc.
Via GlobeNewswire
Tickers SEER
Seer to Report First Quarter 2025 Financial Results on May 13, 2025
From Seer, Inc.
Via GlobeNewswire
Tickers SEER
Seer Reports Fourth Quarter and Full Year 2024 Financial Results and Provides Full Year 2025 Outlook
From Seer, Inc.
Via GlobeNewswire
Tickers SEER
Seer to Participate in the TD Cowen 45th Annual Health Care Conference
From Seer, Inc.
Via GlobeNewswire
Tickers SEER
Seer to Feature Proteomic Advancements in Cancer and RNA Therapy Research among other Findings at US HUPO 2025
From Seer, Inc.
Via GlobeNewswire
Tickers SEER
Seer to Report Fourth Quarter and Full Year 2024 Financial Results on February 27, 2025
From Seer, Inc.
Via GlobeNewswire
Tickers SEER
Seer to Present at the J.P. Morgan 43rd Annual Healthcare Conference
From Seer, Inc.
Via GlobeNewswire
Tickers SEER
Seer Ranked Number 57 Fastest-Growing Company in North America on the 2024 Deloitte Technology Fast 500™
From Seer, Inc.
Via GlobeNewswire
Tickers SEER
Seer to Participate in Upcoming November Investor Conferences
From Seer, Inc.
Via GlobeNewswire
Tickers SEER
Seer Reports Third Quarter 2024 Financial Results
From Seer, Inc.
Via GlobeNewswire
Tickers SEER
Seer Enters into a Co-Marketing and Sales Agreement with Thermo Fisher Scientific
From Seer, Inc.
Via GlobeNewswire
Tickers SEER
Seer Highlights Capability of Deep Proteomics to Enhance Genomic Insights Into Alzheimer’s, Lung Cancer, and More at ASHG 2024
From Seer, Inc.
Via GlobeNewswire
Tickers SEER
Seer Showcases Scalable Proteomic Advancements Impacting Alzheimer’s, Population Health, and Xenotransplantation at HUPO 2024
From Seer, Inc.
Via GlobeNewswire
Tickers SEER
Seer to Report Third Quarter 2024 Financial Results on November 6, 2024
From Seer, Inc.
Via GlobeNewswire
Tickers SEER
Seer to Participate in the Morgan Stanley 22nd Annual Global Healthcare Conference
From Seer, Inc.
Via GlobeNewswire
Tickers SEER
Seer Appoints Nicolas Roelofs to its Board of Directors
From Seer, Inc.
Via GlobeNewswire
Tickers SEER
Seer to Participate in the Canaccord Genuity 44th Annual Growth Conference
From Seer, Inc.
Via GlobeNewswire
Tickers SEER
Seer Reports Second Quarter 2024 Financial Results
From Seer, Inc.
Via GlobeNewswire
Tickers SEER
Seer to Report Second Quarter 2024 Financial Results on August 8, 2024
From Seer, Inc.
Via GlobeNewswire
Tickers SEER
Seer Proteograph™ Provides Differentiated Insights into Spaceflight Proteomic Alterations for Precision Medicine and Biomarker Discovery
From Seer, Inc.
Via GlobeNewswire
Tickers SEER
Seer Technology Access Center Provides Unprecedented Scale and Depth of Coverage for PrognomiQ’s Early Cancer Detection Study
From Seer, Inc.
Via GlobeNewswire
Tickers SEER
Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the Privacy Policy and Terms Of Service.
© 2025 FinancialContent. All rights reserved.